Han Kun Partner Mr. Zhu Min Invited to Participate in a Seminar Hosted by the Guangdong Biomedical Innovation and Technology Association
2016-09-12
On September 10, 2016, the Guangdong Biomedical Innovation and Technology Association (the “Association”), Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., Baiyunshan Pharmaceutical General Factory, Guangzhou Boji Medical Biotechnology Co., Ltd. and Hybio Pharmaceutical Co., Ltd. jointly held a seminar entitled "Sharing Experiences with respect to Conformity Assessment Projects & the Marketing Authorization Holder System”. Over 120 people from relevant government departments, pharmaceutical companies and research institutions attended the seminar.
At the seminar, several representative companies from Guangdong shared their experiences on the implementation of conformity assessment projects. Officers from the Guangdong Food and Drug Administration also introduced the situation on the implementation of MAH system in Guangdong. Han Kun Partner, Mr. Zhu Min was invited to the seminar and gave a presentation entitled “Analysis on Policies and Legal Issues related to the MAH System”.
The Association was founded under the direction of the Guangdong Food and Drug Administration in 2014, and is a provincial non-profit social organization with independent legal personality registered with the Department of Civil Affairs of Guangdong Province. The Association is comprised of members including pharmaceutical production enterprises, R&D enterprises, drug clinical trial institutions, CRO companies and universities, with the aim to guide enterprises to make prospective project investments, promote R&D institutions to introduce corporate mechanisms, extend the value chain of technological innovation and support innovative development in the Guangdong biotechnology industry.